Hugel

formerly Hugel PharmaIPO

Power That Makes You Shine

Hugel is a biotech company in Chuncheon, South Korea, founded in 2001. It has raised $831.0M across 1 round, most recently an $831.0M Private Equity in June 2017.

Headquarters
Chuncheon
Employees
201–500
Founded
2001
Business Model
B2B
Total Funding
$831.0M
Last Round
$831.0M Private EquityJun 2017
Rounds
1
Type
Public
Ticker
145020 · KRX

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 4 investors for this company. to use credits for reveals, or explore the API.

About

Hugel is a South Korean global leader in medical aesthetics founded in 2001, producing botulinum toxin (Botulax/Letybo), hyaluronic acid fillers, skin boosters, threads, and bio-cosmetics. Present in over 70 countries, Hugel received US FDA approval for Letybo in 2024, challenging established neurotoxin brands. The company serves healthcare professionals worldwide through academic programs and maintains strict international quality and manufacturing standards.

Funding History

Data from Indexed.vcUpdated
Secondary MarketMajority Stake SaleAug 2021

1 more funding event

  • Private Equity20171 investor

Funding: Private Equity. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Cloud/Infrastructure ×1
  • Frontend ×1
  • Marketing & SEO ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Hugel on Indexed.vc
<a href="https://indexed.vc/companies/hugel"><img src="https://indexed.vc/api/badge/company/hugel" alt="Hugel on Indexed.vc" width="260" height="76" /></a>